AcelRx Will Overcome Its Recent Stock Woes [Seeking Alpha]
AcelRx Pharmaceuticals, Inc. (ACRX)
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.acelrx.com/investor-relations
Company Research
Source: Seeking Alpha
Summary Last Friday, exactly one year after previously receiving a CRL from the FDA, AcelRx Pharmaceuticals' ( ACRX ) lead drug candidate Dsuvia received a 10-3 vote from an FDA Advisory Committee - according to the Advisory Committee, the benefits of approving Dsuvia for use in a medically supervised setting outweigh the risks. As a result, it seems likely that the FDA will issue an official approval for Dsuvia sometime in the weeks leading up to the drug's November 3 PDUFA date. However, ACRX's stock has been performing poorly, contrary to general expectations. On Tuesday, ACRX closed at a price of $3.97 - one cent lower than its closing price the day before the all-important AdCom meeting. Is AcelRx Bottoming Out? After closing at $3.98 on Thursday, October 11, ACRX was halted for trading on Friday during the AdCom meeting. After receiving a positive vote from the AdCom, ACRX's stock was reopened for trading at 4:45 PM, at which point it jumped up rapidly to around
Show less
Read more
Impact Snapshot
Event Time:
ACRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACRX alerts
High impacting AcelRx Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics